What is NDC 60687-549?

60687-549 is the product NDC for Ranolazine, Ranolazine 500 mg/1 tablet, extended release, listed with the FDA by American Health Packaging. It has 1 package NDC, shown above in 10- and 11-digit form.

American Health Packaging, NDC labeler code 60687. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Ranolazine?

53 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Ranolazine NDC 60687-549 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)60687-549Labeler and product segments. Claims need a package NDC.

Product NDC at billing width60687-0549Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
60687-549-21	60687054921	30 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-549-21) / 1 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (60687-549-11)Marketed from Aug 19, 2020

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Ranolazine
Generic name (nonproprietary): ranolazine
Active ingredients: Ranolazine — 500 mg/1
Dosage form: Tablet, Extended release
Route: Oral
Labeler: American Health PackagingNDC labeler code 60687
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 210054
Marketing start: Aug 19, 2020
Listing expires: Dec 31, 2027
Other FDA classes: Cytochrome P450 2D6 Inhibitors (Mechanism)Cytochrome P450 3A Inhibitors (Mechanism)Organic Cation Transporter 2 Inhibitors (Mechanism)P-Glycoprotein Inhibitors (Mechanism)
Identifiers: Product ID 60687-549_596834c7-18f1-07a0-e063-6294a90a9df6SPL ID 596834c7-18f1-07a0-e063-6294a90a9df6SPL set ID 90c5a0c2-542c-467e-9c0c-ef320534c560RxCUI 616749UNII A6IEZ5M406
Pharmacologic class: Anti-anginal

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N460687054921 followed by a unit qualifier and the quantity

Package 60687-0549-21. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 19, 2026.

Indications (excerpt from the label)

Ranolazine extended-release tablets are indicated for the treatment of chronic angina. Ranolazine extended-release tablets may be used with beta-blockers, nitrates, calcium channel blockers, anti-platelet therapy, lipid-lowering therapy, ACE inhibitors, and angiotensin receptor blockers. Ranolazine is an antianginal indicated for the treatment of chronic angina. (1)

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 60687-549

What is NDC 60687-549?: 60687-549 is the product NDC for Ranolazine, Ranolazine 500 mg/1 tablet, extended release, listed with the FDA by American Health Packaging. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Ranolazine.
What is the active ingredient?: Ranolazine.
Who is the labeler?: American Health Packaging, NDC labeler code 60687. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Ranolazine?: 53 other product NDCs are listed under this name. See all Ranolazine NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Ranolazine NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Ranolazine	Ranolazine 500 mg/1	Tablet, Extended releaseOral	Umedica Laboratories USA Inc.	60290-055	60290-0055-0160290-0055-03
Ranolazine	Ranolazine 1000 mg/1	Tablet, Extended releaseOral	Umedica Laboratories USA Inc.	60290-056	60290-0056-0160290-0056-03
Ranolazine	Ranolazine 500 mg/1	Tablet, Film coated, Extended releaseOral	Torrent Pharma, Inc.	13668-759	13668-0759-60
Ranolazine	Ranolazine 1000 mg/1	Tablet, Film coated, Extended releaseOral	Torrent Pharma, Inc.	13668-760	13668-0760-60
Ranolazine	Ranolazine 500 mg/1	Tablet, Film coated, Extended releaseOral	Zameer Pharmaceuticals LLC	90096-151	90096-0151-60
Ranolazine	Ranolazine 1000 mg/1	Tablet, Film coated, Extended releaseOral	Zameer Pharmaceuticals LLC	90096-152	90096-0152-60
Ranolazine	Ranolazine 500 mg/1	Tablet, Film coated, Extended releaseOral	Aphena Pharma Solutions - Tennessee, LLC	71610-971	71610-0971-42
Ranolazine	Ranolazine 1000 mg/1	Tablet, Film coated, Extended releaseOral	Radha Pharmaceuticals, Inc	77771-424	77771-0424-60
Ranolazine	Ranolazine 500 mg/1	Tablet, Film coated, Extended releaseOral	Radha Pharmaceuticals, Inc	77771-423	77771-0423-60
Ranolazine	Ranolazine 500 mg/1	Tablet, Film coated, Extended releaseOral	A2A Integrated Pharmaceuticals	73141-021	73141-0021-02

All 54 Ranolazine NDCs

Other NDCs under ANDA 210054

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 210054
Product	Strength	Form · route	Labeler	Product NDC
Ranolazine	Ranolazine 500 mg/1	Tablet, Extended releaseOral	Ajanta Pharma USA Inc.	27241-125
Ranolazine	Ranolazine 1000 mg/1	Tablet, Extended releaseOral	Ajanta Pharma USA Inc.	27241-126